News Column

CYTORI THERAPEUTICS, INC. FILES (8-K) Disclosing Unregistered Sale of Equity Securities, Financial Statements and Exhibits

May 16, 2014

Item 3.02 Unregistered Sales of Equity Securities.

Effective May 13, 2014, Cytori Therapeutics, Inc. (the "Company") and 47 holders of warrants dated May 14, 2009 (the "Warrants") to purchase a total of 3,156,238 shares of the Company's common stock, $0.001 par value per share (the "Common Stock"), issued in a private offering in 2009 agreed to extend the expiration date of the Warrants from May 14, 2014 to May 14, 2015 and increase the exercise price of the Warrants from $2.62 per share to $3.50 per share pursuant to an Amendment to Warrant to Purchase Common Stock (the "Amendment"), a form of which is filed as Exhibit 4.1 to this Current Report on Form 8-K and incorporated herein by reference. To the extent the Amendments constitute an issuance of securities, the deemed exchange of the original warrants for warrants with the modified terms for no additional consideration and without paying remuneration for soliciting such exchange was exempt under Section 3(a)(9) of the Securities Act.

One holder of Warrants did not agree to the Amendment and their Warrants, covering 38,500 shares of Common Stock, expired unexercised on May 14, 2014 in accordance with the originals terms of the Warrants.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

4.1 Form of Amendment to Warrant to Purchase Common Stock, dated

effective May 13, 2014.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters